Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.
about
Immunoregulation by mesenchymal stem cells: biological aspects and clinical applicationsWharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host DiseasePI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune PolarizationThe interaction between mesenchymal stem cells and steroids during inflammation.An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy.Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone.New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation.Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsionImproved Protective Effect of Umbilical Cord Stem Cell Transplantation on Cisplatin-Induced Kidney Injury in Mice Pretreated with Antithymocyte GlobulinSide-by-side comparison of the biological characteristics of human umbilical cord and adipose tissue-derived mesenchymal stem cells.Concise review: mesenchymal stem cells and translational medicine: emerging issues.Mesenchymal stem cells: a new trend for cell therapy.In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies.Therapeutic applications of mesenchymal stroma cells in pediatric diseases: current aspects and future perspectivesUmbilical cord as a mesenchymal stem cell source for treating joint pathologies.The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides.Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation.Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.Clinical applications of mesenchymal stem cellsMesenchymal stem cells in the treatment of pediatric diseases.Stromal cells-are they really useful for GVHD?Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells.Melatonin enhances survival and preserves functional integrity of stem cells: A review.A future in our past: the umbilical cord for orthopaedic tissue engineering.Interactions between mesenchymal stem cells and the immune system.Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency.Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system.Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity.Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.Human Umbilical Cord-Derived Mesenchymal Stem Cells Utilize Activin-A to Suppress Interferon-γ Production by Natural Killer Cells.Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation.Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation.Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?Stem Cell Banking for Regenerative and Personalized Medicine.Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.E-cadherin-mediated contact of endothelial progenitor cells with mesenchymal stem cells through β-catenin signaling.
P2860
Q27026892-AE6F8F96-EC01-445F-BA4A-21848D701A2AQ28083027-372A48B1-8EE1-459C-945F-DE59C7097154Q28831131-3972FBF7-6FDE-4189-B736-DBA517207709Q33695051-DB6DBE51-E0B9-42E9-8B94-495310B872CCQ34387727-D26F468B-469D-4419-BAAD-C193B2F53881Q34480369-DB649C04-99E4-4B27-9B3C-37A72E8AD300Q34991991-A1F08D79-1A43-49E4-8705-1808A69DCE7BQ35653672-58748EC0-4DE6-4D80-99C3-8135E3951848Q36262326-E0477568-FEAD-4436-8225-0FF98CC1807CQ36530432-A1579BD7-1274-471A-9902-6CF1E7611388Q37044121-B298EB65-81EA-44C2-8F2C-5061D3628A16Q37056276-F0B8A539-85D2-4410-A975-9C6E3CF78AF2Q37729093-85D4A7D4-0EE6-4FD5-98FF-ECE2D204450CQ37947420-42E59366-A3B4-456D-8391-879E165A473DQ37950842-6C39E3F5-2330-4449-ABAF-9F179CD1E8DFQ37999799-CA5F43BC-B597-4B8F-B4D2-86B2E8B0FC38Q38052233-BE55B06C-EE1A-49DA-9062-86D63A33BF31Q38055145-559768F0-B81A-46ED-8EA6-A8370ADFB18FQ38110707-715EED8E-7550-40AF-8DFD-443BB8578239Q38122364-142C81E0-CB45-4378-83B9-0349EC45E4A7Q38127615-AD4931E6-C447-4374-8C9B-4E1446691214Q38181957-785BA12A-CF73-4101-B453-BCDE297A749DQ38275024-2955D9DE-2098-4E87-A7F6-336CF4EC6FB1Q38979530-B90C80AE-B05A-4CBE-8D34-225E1C35BC8BQ39052439-23C1E646-C5C5-4ABC-BFD0-2CA11670C9EDQ39142316-AC50A097-AF43-43E9-80AB-BE59F292B6E9Q40092032-E3474895-A2C5-49A0-AE3F-44FDF2C5213EQ40785927-30E5998E-1CDC-4E86-AE32-36DE3959909CQ41789455-AEEACF74-7A28-4CD5-9D52-7130B4F95BFFQ42325850-D1EE5E34-D147-4BDF-AE41-480FB2301CFCQ43082916-D9D7DCC6-A393-45AD-8B97-5AF4631BF962Q43942762-77DA352A-A9B2-408C-8022-641FD1526A30Q47787016-80D9FD9A-8879-41EB-9E92-B85FC3D252F9Q50224283-B1581E52-9B7B-4DBF-B4D7-8E522994E6FAQ51301197-DAD602A1-2F03-47D0-8D9F-693BBC977B6BQ52680964-9436F601-1A2D-495D-BB19-1B26D8B59F4BQ52917325-9C93D7BC-3844-4AA7-9DE7-03B31B2E63BFQ53211327-CF6D4D48-40B5-41A9-8594-12FE9A00D3A9
P2860
Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effective treatment of severe ...... erived mesenchymal stem cells.
@en
Effective treatment of severe ...... erived mesenchymal stem cells.
@nl
type
label
Effective treatment of severe ...... erived mesenchymal stem cells.
@en
Effective treatment of severe ...... erived mesenchymal stem cells.
@nl
prefLabel
Effective treatment of severe ...... erived mesenchymal stem cells.
@en
Effective treatment of severe ...... erived mesenchymal stem cells.
@nl
P2093
P1433
P1476
Effective treatment of severe ...... derived mesenchymal stem cells
@en
P2093
Chin-Kan Chan
Ching-Tien Peng
Chris Tsai
Han-Ping Wu
Kang-Hsi Wu
Martin Sieber
Tsan-Hung Chiu
Yu-Hsiang Chang
P304
P356
10.1097/TP.0B013E31821ABA18
P577
2011-06-01T00:00:00Z